FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely phthisiology. The patient is exposed to three-field low intensity laser skin irradiation in a projection of pathological process in lungs and then spleen at wave length 0.85-0.95 nm in infra-red range. Pulse power is 7 Wt, pulse repetition rate is 2.5 kHz, modulating frequency is 100 Hz, and exposition time is 2 minutes per each field. One session lasts for 8 minutes, for therapeutic course 10 sessions every second day.
EFFECT: fast regress of clinical, laboratory and radiological manifestations of the disease, reduced treatment time.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ACTIVE FORMS OF PULMONARY TUBERCULOSIS | 2015 |
|
RU2599972C1 |
METHOD OF COMPLEX TREATMENT OF PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2023 |
|
RU2797991C1 |
METHOD FOR CHOOSING THERAPEUTIC APPROACH FOR PATIENTS WITH NEWLY DIAGNOSED INFILTRATIVE PULMONARY TUBERCULOSIS | 2015 |
|
RU2602683C1 |
METHOD FOR TREATMENT OF DESTRUCTIVE AND PROGRESSING LUNG TUBERCULOSIS FORMS CAUSED BY DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS | 2000 |
|
RU2215538C2 |
METHOD OF TREATMENT OF ACTIVE PULMONARY CONSUMPTION | 0 |
|
SU1790406A3 |
METHOD OF PULMONARY TUBERCULOSIS TREATMENT | 2006 |
|
RU2329782C1 |
METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS | 2001 |
|
RU2229892C2 |
METHOD FOR TREATING PULMONARY TUBERCULOSIS AT PREDOMINANTLY PRODUCTIVE TYPE OF TISSUE REACTION | 2000 |
|
RU2204409C2 |
METHOD FOR TREATING THE CASES OF PULMONARY TUBERCULOSIS PATIENTS FOR ENDOBRONCHITIS | 2003 |
|
RU2228776C1 |
METHOD OF DETERMINING INDIVIDUAL SUSCEPTIBILITY OF TUBERCULOUS PATIENTS TO TUBERCULIN | 0 |
|
SU1364982A1 |
Authors
Dates
2009-12-10—Published
2007-09-19—Filed